Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 194

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects

Chironi, Gilles, Simon, Alain, Hugel, Bénédicte, Del Pino, Muriel, Gariepy, Jérôme, Freyssinet, Jean-Marie, Tedgui, Alain · 2006 · Arteriosclerosis, Thrombosis, and Vascular Biology

Abstract

Objective— To clarify circulating microparticles (MP) relationships with preclinical atherosclerosis. Methods and Results— In 216 subjects without cardiovascular disease, we assessed: (1) annexin V-positive, platelet-derived, endothelium-derived and leukocyte-derived circulating MP by capture on annexin V, anti-GPIb, anti-CD105, and anti-CD11a antibody-coated wells, respectively; (2) Framingham risk, metabolic syndrome, and low-grade inflammation by risk factors measurement including hsCRP; and (3) subclinical atherosclerosis by ultrasound examination of carotid, abdominal aorta, and femoral arteries. Number of sites with plaque ranged from 0 to 3 and plaque burden was classified into 0 to 1 or 2 to 3 sites disease. Leukocyte-derived MP level was higher in the presence than in the absence of moderate to high Framingham risk ( P <0.05), metabolic syndrome ( P <0.01), high C-reactive protein (CRP) ( P <0.05), or 2- to 3-sites disease ( P <0.01), and correlated positively with number of metabolic syndrome components ( P <0.001), tertiles of fibrinogen ( P <0.001), and number of diseased sites ( P <0.01). In multivariate analysis, 2- to 3-sites disease was independently associated with leukocyte-derived MP level ( P <0.05), Framingham risk ( P <0.001), and metabolic syndrome ( P <0.01). None of the other MP types correlated with risk markers or atherosclerosis. Conclusions— Leukocyte-derived MP, identified by affinity for CD11a, are increased in subjects with ultrasound evidence of subclinical atherosclerosis, unveiling new directions for atherosclerosis research.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.atv.0000249639.36915.04

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 194

Metadata

Authors
Chironi, G., Simon, A., Hugel, B., Del Pino, M., Gariepy, J., Freyssinet, J.-M., & Tedgui, A.
Venue
Arteriosclerosis, Thrombosis, and Vascular Biology
Published
2006-12
Volume
26
Issue
12
Pages
2775-2780
ISSN
  • 1079-5642 (ISSN-L)
  • 1524-4636
OpenAlex
W2099391433
Cited by
194
References
5
FWCI
3.93
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects. https://app.cochat.ai/papers/10.1161/01.atv.0000249639.36915.04
The paper
Chironi, G., Simon, A., Hugel, B., Del Pino, M., Gariepy, J., Freyssinet, J.-M., & Tedgui, A. (2006). Circulating Leukocyte-Derived Microparticles Predict Subclinical Atherosclerosis Burden in Asymptomatic Subjects. Arteriosclerosis, Thrombosis, and Vascular Biology. https://doi.org/10.1161/01.atv.0000249639.36915.04

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.